Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fidock

Showing results (71-80 of 302) with videos related to

Pageof 31
Sort By:
Plos Computational Biology|January 28, 2014
Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria eliminationGeoffrey L Johnston, Peter W Gething, Simon I Hay, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 31, 2006
First evidence of pfcrt mutant Plasmodium falciparum in MadagascarMilijaona Randrianarivelojosia, David A Fidock, Olivier Belmonte, et al.
Mbio|April 13, 2017
<i>Plasmodium falciparum</i> K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness <i>In Vitro</i>Judith Straimer, Nina F Gnädig, Barbara H Stokes, et al.
Biochemistry|July 20, 2005
Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparumCecilia P Sanchez, Jeremy E McLean, Petra Rohrbach, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2013
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent modelPhilipp P Henrich, Connor O'Brien, Fabián E Sáenz, et al.
Molecular Microbiology|April 9, 2005
Defining the role of PfCRT in Plasmodium falciparum chloroquine resistancePatrick G Bray, Rowena E Martin, Leann Tilley, et al.
Molecular Microbiology|May 12, 2007
Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparumCecilia P Sanchez, Petra Rohrbach, Jeremy E McLean, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium speciesSergio Wittlin, Eric Ekland, J Carl Craft, et al.
Mbio|November 11, 2020
Plasmodium berghei K13 Mutations Mediate <i>In Vivo</i> Artemisinin Resistance That Is Reversed by Proteasome InhibitionNelson V Simwela, Barbara H Stokes, Dana Aghabi, et al.
Trends in Parasitology|May 18, 2021
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarialsMaëlle Duffey, Benjamin Blasco, Jeremy N Burrows, et al.
Pageof 31

Showing results (71-80 of 302) with videos related to

Sort By:
Pageof 31
Plos Computational Biology|January 28, 2014
Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria eliminationGeoffrey L Johnston, Peter W Gething, Simon I Hay, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 31, 2006
First evidence of pfcrt mutant Plasmodium falciparum in MadagascarMilijaona Randrianarivelojosia, David A Fidock, Olivier Belmonte, et al.
Mbio|April 13, 2017
<i>Plasmodium falciparum</i> K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness <i>In Vitro</i>Judith Straimer, Nina F Gnädig, Barbara H Stokes, et al.
Biochemistry|July 20, 2005
Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparumCecilia P Sanchez, Jeremy E McLean, Petra Rohrbach, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2013
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent modelPhilipp P Henrich, Connor O'Brien, Fabián E Sáenz, et al.
Molecular Microbiology|April 9, 2005
Defining the role of PfCRT in Plasmodium falciparum chloroquine resistancePatrick G Bray, Rowena E Martin, Leann Tilley, et al.
Molecular Microbiology|May 12, 2007
Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparumCecilia P Sanchez, Petra Rohrbach, Jeremy E McLean, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium speciesSergio Wittlin, Eric Ekland, J Carl Craft, et al.
Mbio|November 11, 2020
Plasmodium berghei K13 Mutations Mediate <i>In Vivo</i> Artemisinin Resistance That Is Reversed by Proteasome InhibitionNelson V Simwela, Barbara H Stokes, Dana Aghabi, et al.
Trends in Parasitology|May 18, 2021
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarialsMaëlle Duffey, Benjamin Blasco, Jeremy N Burrows, et al.
Pageof 31